Moon Young-Wook, Dobroski Timothy, Willson Kelsey, Jeong Jin-Oh, Bishop Colin, Atala Anthony, Yoo James J, Lee Sang Jin
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, United States.
Mater Today Bio. 2025 Apr 21;32:101786. doi: 10.1016/j.mtbio.2025.101786. eCollection 2025 Jun.
Establishing adequate vascularization to engineered organs remains a significant challenge that must be addressed. This study presents a novel approach to fabricating viable thick metabolic tissue (>1 cm) for applications in human physiology, fundamental biology, and medicine. We designed a tissue construct with a gyroid-shaped architecture to enable uniform flow and surface shear stress that adequately covers the inner surfaces of cell-laden constructs. The constructs (1 × 1 × 1 cm) were fabricated using a digital light projection (DLP) printer with a cell-laden poly(ethylene glycol) (PEG)/gelatin methacryloyl (GelMA) bioink combined with human hepatocytes (HepG2), followed by coating the interconnected vascular channels with human endothelial cells (ECs). These constructs were then placed in flow chambers connected to a medium reservoir for continuous perfusion for up to 30 days. The constructs retained their original dimensions, and the cells maintained a greater than 85 % viability at all time points. Immunofluorescent staining confirmed hepatocytes and ECs using cell-specific markers (HNF4-α/albumin for hepatocytes and vWF for ECs). The EC layer effectively lined the vascular lumens, while viable hepatocyte aggregates populated the interior of the constructs. Functional assays demonstrated that the hepatocytes produced albumin and bilirubin at levels comparable to those observed in humans, validating the metabolic functionality of the hepatic tissue constructs. This study successfully developed thick, vascularized human hepatic tissue in an environment, maintaining functionality comparable to native liver cells over 30 days. The innovative gyroid design applied in these organ constructs represents a significant advancement in developing physiologically relevant vascularized organ models.
为工程化器官建立充足的血管化仍然是一个必须解决的重大挑战。本研究提出了一种新颖的方法来制造用于人类生理学、基础生物学和医学应用的有活力的厚代谢组织(>1厘米)。我们设计了一种具有螺旋状结构的组织构建体,以实现均匀的流动和表面剪切应力,从而充分覆盖载有细胞的构建体的内表面。使用数字光投影(DLP)打印机,将载有细胞的聚乙二醇(PEG)/甲基丙烯酸明胶(GelMA)生物墨水与人类肝细胞(HepG2)结合,制造出构建体(1×1×1厘米),随后用人内皮细胞(ECs)覆盖相互连接的血管通道。然后将这些构建体放置在与培养基储存器相连的流动室中,进行长达30天的连续灌注。构建体保持其原始尺寸,并且在所有时间点细胞活力均维持在85%以上。免疫荧光染色使用细胞特异性标记物(肝细胞用HNF4-α/白蛋白,内皮细胞用vWF)证实了肝细胞和内皮细胞的存在。内皮细胞层有效地排列在血管腔内,而有活力的肝细胞聚集体填充在构建体内部。功能测定表明,肝细胞产生白蛋白和胆红素的水平与在人类中观察到的水平相当,验证了肝组织构建体的代谢功能。本研究在体外成功开发出了厚的、血管化的人类肝组织,在30天内维持了与天然肝细胞相当的功能。应用于这些器官构建体的创新螺旋状设计代表了在开发生理相关的血管化器官模型方面的重大进展。